+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Medical Affairs Outsourcing Market by Services (Medical Communications, Medical Information Services, Medical Monitoring), Operational Model (Full-Service Outsourcing, Functional Outsourcing, Partial/Task-based Outsourcing), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4896732
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Medical Affairs Outsourcing Market size was estimated at USD 9.78 billion in 2023, USD 11.16 billion in 2024, and is expected to grow at a CAGR of 14.59% to reach USD 25.39 billion by 2030.

Medical affairs is an essential function within the life sciences industry, encompassing a wide range of activities that bridge the gaps between clinical development, commercialization, and engagement with healthcare stakeholders. Medical affairs outsourcing refers to the practice of entrusting these activities, including medical writing, medical communications, publication planning, field medical engagement, medical information services, and health economics and outcomes research (HEOR) to external organizations with specialized expertise. As therapies become more complex, the demand for specialized medical affairs services grows. Companies entering new markets also seek local medical affairs support to navigate different regulatory landscapes. The robust pipeline of pharmaceutical and biotech companies broadens the potential for outsourcing services. However, challenges such as ensuring data security and maintaining quality control remain significant hurdles. While market players are focusing on improving service compliance and offerings, they are also developing tailored medical affairs strategies to support personalized therapies and are leveraging real-world evidence to demonstrate product value and inform clinical strategies. Digitalization and AI in medical affairs could also offer innovative outsourcing services.

Regional Insights

In the Americas, particularly in the United States and Canada, there is a significant emphasis on compliance and transparency in pharmaceutical operations. Firms in these regions often outsource medical affairs activities to maintain high levels of regulatory compliance and to gain strategic insights from external experts. With a highly developed pharmaceutical industry, the Americas generally show a mature outsourcing market characterized by the engagement of sophisticated CROs and medical affairs service providers. The APAC region is marked by its diverse healthcare markets, with countries at different stages of pharmaceutical industry development. Outsourcing in APAC is rapidly growing, driven by the emergence of local players and increasing investments by global companies. The rise in the number of clinical trials, growing demand for specialized medical services, and cost advantages are significant factors contributing to the expansion of Medical Affairs outsourcing in APAC. Companies in APAC turn to outsourcing to gain access to regional expertise, expand their market reach, and capitalize on the growing healthcare needs of populous countries, including China and India. EMEA encompasses a vast region with a wide variety of healthcare systems and regulatory environments. In Europe, medical affairs outsourcing is well-established, with many companies leveraging the services of CROs and other specialized firms, particularly for market access and health economics outcomes research (HEOR). The Middle East and Africa are emerging markets for outsourcing, with multinational companies exploring these regions for expansion.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Medical Affairs Outsourcing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Medical Affairs Outsourcing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Medical Affairs Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, Ashfield Healthcare Communications by Inizio, Biomapas Group, Charles River Laboratories International, Inc., Comprehend Systems, Inc. by Saama Technologies, Inc., Excelya, Freyr Solutions, Genpact, Groupe ProductLife S.A., ICON PLC, Indegene, Inc., Insuvia, IQVIA Holdings, Inc., JSS Medical Research Inc, Medpace Holdings, Inc., MMS Holdings Inc., PAREXEL International Corporation, Pharmalex by BlueReg, PPD, Inc. by Thermo Fischer Scientific Inc., ProPharma Group, SGS S.A., Syneos Health, Inc., The Medical Affairs Company, Wuxi Clinical Development, Inc., and Zeincro Group.

Market Segmentation & Coverage

This research report categorizes the Medical Affairs Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Medical Communications
    • Medical Information Services
    • Medical Monitoring
    • Medical Science Liaisons
    • Medical Writing & Publishing
  • Operational Model
    • Full-Service Outsourcing
    • Functional Outsourcing
    • Partial/Task-based Outsourcing
  • End-User
    • Biotechnology & Pharmaceutical Companies
    • Contract Research Organization
    • Hospitals
    • Medical Device Companies
    • Nursing Homes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Medical Affairs Outsourcing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Medical Affairs Outsourcing Market?
  3. What are the technology trends and regulatory frameworks in the Medical Affairs Outsourcing Market?
  4. What is the market share of the leading vendors in the Medical Affairs Outsourcing Market?
  5. Which modes and strategic moves are suitable for entering the Medical Affairs Outsourcing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Medical Affairs Outsourcing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adoption of cost-saving measures with changing reimbursement policies in pharmaceutical sector
5.1.1.2. Potential demand attributed to high cost involved in training and R&D process
5.1.1.3. Availability of price-efficient solutions and compliance with regulatory protocols
5.1.2. Restraints
5.1.2.1. High cost involved in R&D of the pharmaceutical sector
5.1.3. Opportunities
5.1.3.1. Ongoing focus on core activities such as drug development in pharmaceutical companies
5.1.3.2. Surge in outsourcing of medical affairs such as medical material, field based medical teams and medical publications
5.1.4. Challenges
5.1.4.1. Concerns over data breaches and security
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Medical Affairs Outsourcing Market, by Services
6.1. Introduction
6.2. Clinical Trial Applications & Product Registrations
6.3. Regulatory Consulting & Legal Representation
6.4. Regulatory Writing & Publishing
7. Medical Affairs Outsourcing Market, by End-User
7.1. Introduction
7.2. Biotechnology Companies
7.3. Mid- Sized Pharmaceutical Companies
8. Americas Medical Affairs Outsourcing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Medical Affairs Outsourcing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Medical Affairs Outsourcing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Accell Clinical Research, LLC
12.1.2. Charles River Laboratories International, Inc.
12.1.3. Clinilabs, Inc.
12.1.4. Covance, Inc.
12.1.5. Criterium, Inc.
12.1.6. Genpact Ltd
12.1.7. ICON plc
12.1.8. Indegene, Inc.
12.1.9. Medpace, Inc.
12.1.10. Parexel International Corporation
12.1.11. Pharmaceutical Product Development, LLC
12.1.12. PRA Health Sciences, Inc.
12.1.13. Promedica International
12.1.14. Syneos Health, Inc.
12.1.15. WuXi AppTec Co., Ltd
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. MEDICAL AFFAIRS OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 2. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2022 VS 2030
FIGURE 3. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. MEDICAL AFFAIRS OUTSOURCING MARKET DYNAMICS
FIGURE 7. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2022 VS 2030 (%)
FIGURE 8. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 10. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. MEDICAL AFFAIRS OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. MEDICAL AFFAIRS OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. MEDICAL AFFAIRS OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 6. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL APPLICATIONS & PRODUCT REGISTRATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING & LEGAL REPRESENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY WRITING & PUBLISHING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 10. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MID- SIZED PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 20. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 21. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 22. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. CHINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 32. CHINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. INDIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 34. INDIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. INDONESIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 38. JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. MALAYSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. PHILIPPINES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. SINGAPORE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. TAIWAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 50. THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. VIETNAM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 57. DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. EGYPT MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 59. EGYPT MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. FINLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 61. FINLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 63. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 65. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 69. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. NETHERLANDS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. NIGERIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 75. NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. POLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 77. POLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. QATAR MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 79. QATAR MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 87. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. SWITZERLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. TURKEY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 93. TURKEY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. MEDICAL AFFAIRS OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 99. MEDICAL AFFAIRS OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 100. MEDICAL AFFAIRS OUTSOURCING MARKET LICENSE & PRICING

Companies Mentioned

  • Accenture PLC
  • Ashfield Healthcare Communications by Inizio
  • Biomapas Group
  • Charles River Laboratories International, Inc.
  • Comprehend Systems, Inc. by Saama Technologies, Inc.
  • Excelya
  • Freyr Solutions
  • Genpact
  • Groupe ProductLife S.A.
  • ICON PLC
  • Indegene, Inc.
  • Insuvia
  • IQVIA Holdings, Inc.
  • JSS Medical Research Inc
  • Medpace Holdings, Inc.
  • MMS Holdings Inc.
  • PAREXEL International Corporation
  • Pharmalex by BlueReg
  • PPD, Inc. by Thermo Fischer Scientific Inc.
  • ProPharma Group
  • SGS S.A.
  • Syneos Health, Inc.
  • The Medical Affairs Company
  • Wuxi Clinical Development, Inc.
  • Zeincro Group

Methodology

Loading
LOADING...

Table Information